Treatment of Nonalcoholic Fatty Liver Disease in Children (TONIC)
Status:
Completed
Trial end date:
2010-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if therapeutic modification of insulin resistance
or oxidative stress leads to improvement in serum or histologic indicators of liver injury or
quality of life.
Phase:
Phase 3
Details
Lead Sponsor:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Treatments:
alpha-Tocopherol Metformin Tocopherols Tocotrienols Vitamin E Vitamins